Gene · 7516
Papers1,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Relationship between autoimmunity and COPD: an investigation based on proteomic profiling and antinuclear antibody screening. | J Immunoassay Immunochem | 2025 | 40329569 | PubTator, text mining | PubMed |
| Bioinformatics Combined With Biological Experiments to Identify the Pathogenetic Link of Type 2 Diabetes for Breast Cancer. | Cancer Med | 2025 | 40202151 | PubTator, text mining | PubMed |
| Biochemical Mechanisms of Genetic Recombination and DNA Repair. | Annu Rev Biochem | 2025 | 40153609 | PubTator, text mining | PubMed |
| Discovery of novel xanthohumol C derivatives regulating XRCC2 transcription and expression for the treatment of colorectal cancer. | Bioorg Med Chem | 2025 | 39731930 | PubTator, text mining | PubMed |
| IL-6 Exacerbates Oxidative Damage of RPE Cells by Indirectly Destabilizing the mRNA of DNA Repair Genes. | Inflammation | 2025 | 39581910 | PubTator, text mining | PubMed |
| XRCC2 knockdown effectively sensitizes esophageal cancer to albumin-paclitaxel in vitro and in vivo. | Biochem Genet | 2025 | 39048769 | PubTator, text mining | PubMed |
| Possible New Candidates Involved to Thalidomide-Related Limbs and Cardiac Defects: A Systems Biology Approach. | Biochem Genet | 2025 | 38689186 | PubTator, text mining | PubMed |
| Interaction of breast cancer-relevant DNA repair genes and air pollution in relation to breast cancer risk in UK biobank. | Am J Cancer Res | 2024 | 39803660 | PubTator, text mining | PubMed |
| Genetic Polymorphisms of DNA Repair Genes and their Influence on Paclitaxel based Chemotherapy Induced Toxicity Reactions in Breast Cancer Patients. | Asian Pac J Cancer Prev | 2024 | 39733420 | PubTator, text mining | PubMed |
| High- and Moderate-Risk Variants Among Breast Cancer Patients and Healthy Donors Enrolled in Multigene Panel Testing in a Population of Central Russia. | Int J Mol Sci | 2024 | 39684352 | PubTator, text mining | PubMed |
| Somatic gene mutations involved in DNA damage response/Fanconi anemia signaling are tissue- and cell-type specific in human solid tumors. | Front Med (Lausanne) | 2024 | 39421870 | PubTator, text mining | PubMed |
| RAD51 Paralogs and RAD51 Paralog Complexes BCDX2 and CX3 Interact with BRCA2. | bioRxiv | 2024 | 39416194 | PubTator, text mining | PubMed |
| The role of RAD51 regulators and variants in primary ovarian insufficiency, endometriosis, and polycystic ovary syndrome. | NAR Mol Med | 2024 | 39359934 | PubTator, text mining | PubMed |
| Mechanism of BCDX2-mediated RAD51 nucleation on short ssDNA stretches and fork DNA. | Nucleic Acids Res | 2024 | 39268578 | PubTator, text mining | PubMed |
| Identifying crucial lncRNAs and mRNAs in hypoxia-induced A549 lung cancer cells and investigating their underlying mechanisms via high-throughput sequencing. | PLoS One | 2024 | 39236027 | PubTator, text mining | PubMed |
| Targeting proliferating cell nuclear antigen enhances ionizing radiation-induced cytotoxicity in prostate cancer cells. | Prostate | 2024 | 39219052 | PubTator, text mining | PubMed |
| Screening of gastric cancer diagnostic biomarkers in the homologous recombination signaling pathway and assessment of their clinical and radiomic correlations. | Cancer Med | 2024 | 39206620 | PubTator, text mining | PubMed |
| c-Myc-XRCC2-FOS axis promotes the proliferation and the resistance to Doxorubicin of NSCLC. | Biomed Pharmacother | 2024 | 39153434 | PubTator, text mining | PubMed |
| Landscape of homologous recombination deficiency in gastric cancer and clinical implications for first-line chemotherapy. | Gastric Cancer | 2024 | 39110344 | PubTator, text mining | PubMed |
| Association of XRCC2 with breast cancer, a multi-omics analysis at genomic, transcriptomic, and epigenomic level. | Cell Mol Biol (Noisy-le-grand) | 2024 | 39097872 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7516/papers?page=3